Azitra, Inc. Announces Q3 2024 Financial Results and Provides …

Sep 30, 2024 · BRANFORD, Conn. , Nov. 12, 2024 /PRNewswire/ -- Azitra, Inc. (NYSE American: AZTR), a clinical-stage biopharmaceutical company focused on developing innovative …

CouponFollow Extension

$10
OFF

Azitra, Inc. Announces Q3 2024 Financial Results And Provides …

1 week from now

4 days ago · Azitra (AZTR) reported Q3 2024 financial results and business updates. Key highlights include completing a $10 million follow-on offering, dosing the first Netherton …

stocktitan.net

65%
OFF

SenesTech Announces Third Quarter 2024 Financial Results

1 week from now

4 days ago · Gross margin percentages improved to 65% during Q3 2024 compared to 49% in Q3 2023 driven by improvements in manufacturing operations and scale. Gross profit dollars …

stockhouse.com

$152
OFF

DeFi Technologies Inc. Announces Q3 2024 Financial Results: Year …

1 week from now

2 days ago · DeFi Technologies Inc. Announces Q3 2024 Financial Results: Year to Date Revenues of C$152.4 million (US$112.0 million), EBITDA of $102.3 million (US$75.2 million) …

prnewswire.com

FAQs about Azitra, Inc. Announces Q3 2024 Financial Results and Provides … Coupon?

What did azitra do in Q1 2024?

BRANFORD, Conn. -- (BUSINESS WIRE)--May 9, 2024-- Azitra, Inc. (NYSE American: AZTR), a clinical-stage biopharmaceutical company focused on developing innovative therapies for precision dermatology, today reported financial results for the three months ended March 31, 2024, and provided a business update. Q1 2024 and Recent Business Highlights ...

Why did Jason McCarthy buy azitra Inc?

Jason McCarthy has given his Buy rating due to a combination of factors that highlight Azitra Inc’s promising prospects. The company is making significant progress in its lead program, ATR-12, which aims to treat Netherton syndrome. ...

Who is azitra?

About Azitra, Inc. Azitra, Inc. is an early-stage clinical biopharmaceutical company focused on developing innovative therapies for precision dermatology using engineered proteins and topical live biotherapeutic products. ...

When is azitra presenting a late-breaking presentation at eadvcongress 2024?

BRANFORD, Conn.-- (BUSINESS WIRE)---- $AZTR #EADV2024--Azitra will be presenting a late-breaking presentation at #EADVCongress 2024 on Thursday, September 26. ...

Should you buy azitra Inc (aztr)?

In a report released yesterday, Jason McCarthy from Maxim Group maintained a Buy rating on Azitra Inc (AZTR – Research Report), with a price target of $3.00. Jason McCarthy has given his Buy rating due to a combination of factors that highlight Azitra Inc’s promising prospects. ...

Does azitra have egfri-associated rash?

Additionally, Azitra is advancing its ATR-04 program, targeting EGFRi-associated rash, which affects a substantial portion of patients undergoing certain cancer treatments. With an Investigational New Drug (IND) clearance received, the company plans to start a phase 1/2 study soon. ...